Nutrition and metabolic syndrome;Nutrición y síndrome metabólico

Revista Espanola de Salud Publica

Volumn 81, Issue 5, 2007, Pages 489-505

  Martín, Pilar Matía ^a   Pascual, Edurne Lecumberri ^a   Calle Pascual, Alfonso L ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Diabetes mellitus; Diet; Dyslipidemia; Hypertension; Hypertriglyceridemia; Insulin resistance; Metabolic Syndrome X; Obesity; Type 2

Indexed keywords

EID: 39149140361     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: 10.1590/s1135-57272007000500006     Document Type: Review

References (98)

1. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005; 28: 2289-304.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553.
3. The IDF consensus worldwide definition of the metabolic syndrome [citado 14 de oct. 2007]. Disponible en: www.idf.org/webdata/docs/Metac_syndrome_def. pdf.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
5. King H, Rewers M. Diabetes in adults is now a Third World problem. The Who Ad Hoc Diabetes Reporting Group. Bull. World Health Organ. 1991; 69:643-648.
6. King H, Aubert R.E, Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21:1414-1431.
7. Eriksson J, Lindstrom J, Tuomilheto J. Potential for the prevention of type 2 diabetes. Br Med Bull. 200;60:183-199.
8. Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: A review. Diabetes Research and Clinical Practice. 2007; 60:317-326.
9. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995; 122:481-6.
10. Rewers M, Hamman RF (1995). Risk factors for non-insulin dependent diabetes. In: National Diabetes Data Group. Diabetes in America 2nd Edn. NIH Publication No. 95-1468. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. pp. 179-220.
11. Choi BCK, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001; 44:1221-31.
12. Stern L, Iqbal N, Seshadri P, et al. The effects of low carbohydrate versus conventional weight loss in severily obese adults: one year follow-up of a randomized trial. Ann Intern Med. 2004; 140:778-85.
13. Yancy WS, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. Ann Intern Med. 2004; 140:769-77.
14. Reaven GM. Diet and syndrome X. Curr. Atheroscler Rep. 2 2000: 503-507.
15. Pirozzo S, Summerbell C, Cameron C, Glasziou P. Should we recommend low-fat diets for obesity? Obes Rev. 2003; 4:83-90.
16. a edición España: Elsevier; 2005. p. 416-430.
17. Salmeron J, Ascherio A, Rimm EB. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997; 20:545-50.
18. Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997; 277:472-7.
19. Hu FB, Manson JE, Stampfer MJ, Colditz GA, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk type 2 diabetes mellitus in women. N Engl J Med. 2001; 345: 790-97.
20. Foster GD, Wyatt HR, Hill JO. A randomized trial of low-carbohydrate diet for obesity. N Engl J Med. 2003; 348: 2082-90.
21. Kelly S, Frost G, Whittaker V, Summerbell C. Low glycaemic index diets for coronary heart disease. [Systematic Review] Cochrane Heart Group. Database of Systematic Rev 2004: CD004467.
22. Marshall J, Benessen D. Dietary fat and the development of type 2 Diabetes. Diabetes Care. 2002; 25: 620-21.
23. Hu FB, van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 2001; 44: 805-817.
24. The Diabetes and Nutrition study group of the Spanish Diabetes Association (GSEDNu). Diabetes Nutrition and Complications Trial: adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, prospective, populationbased, observational multicenter study. J Diabetes Complications. 2006; 20: 361-6.
25. Hu FB. The Mediterranean Diet and Mortality-Olive oil and beyond. N Engl J Med. 2003; 348: 2595-596.
26. Trichopoulou A, Costacou T, Baemia C, Trichopoulou D. Adherence to a Mediterranean Diet and Survival in a Greek Population. N Engl J Med. 2003; 348: 2599-608.
27. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001; 73:1019-26.
28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilainne-Parikka P. Prevention of type 2 Diabetes Mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344:1343-50.
29. Papakonstantinou E, Panagiotakos D, Pitsavos C, Chrysohoou C, Zampelas A, Skoumas Y. Food group consumption and glycemic control in people with and without type 2 Diabetes. The Attica study. Diabetes Care 2005; 28: 2539-40.
30. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Juosilahti P. Coffee consumption and risk of type 2 Diabetes Mellitus among middle-aged Finnish men and women. JAMA. 2004; 291:1213-1219.
31. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 Diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
32. Van Dam R, Willett W, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 Diabetes. Diabetes Care. 2006; 29: 398-403.
33. Eriksson KF, Lindgarde F. Prevention of type 2 diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 1991; 34:891-98.
34. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX. Effects of diet and exercise in preventing NIDDM in people with impared glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20:537-44.
35. Helmrich S, Ragland D, Leung R, Paffenbarger R. Physical activity and reduced occurrence of noninsulin-dependent diabetes mellitus. N Engl J Med. 1991; 325:147-52.
36. Jeon CP, Lokken P, Hu FB, van Dam R. Physical activity of Moderate Intensity and Risk of Type 2 Diabetes. Diabetes Care. 2007; 30:744-752.
37. Rimm EB, Ellison RC. Alcohol in the Mediterranean Diet. Am J Clin Nutr.1995; 61:1378-82.
38. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm E. Moderate alcohol consumption and risk of coronary heart disease among woman with type 2 Diabetes Mellitus. Circulation. 2000; 102:494-9.
39. Buchanan T, Xiang A, Peters R, Marroquin A, Goico J, Tan S. Preservation of pancreatic beta-cell function and prevention of type 2 Diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002; 51:2796-2803.
40. Xiang A, Peters R, Kjos S, Marroquin A, Goico J, Ochoa C. Effect of pioglitazone on pancreatic beta-cell function and Diabetes risk in Hispanic women with prior Gestational Diabetes. Diabetes. 2006; 55:517-22.
41. Chiasson JL, Josse RG, Gomis R. Acarbose for prevention of type 2 diabetes mellitus : the STOPNIDDM randomized trial. Lancet. 2002; 359:2072-7.
42. Torgerson JS, Hauptman J, Boldrin MN, Sjögstrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004; 27:33-40.
43. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology. 2007; 132: 2181-90.
44. McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, et al. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc. 2006; 54:1317-24.
45. Austin MA. Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol. 1998; 14 Suppl B:14B-17B.
46. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol. 1986;124:624-32.
47. Assmann G, Cullen P, Schulte H. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J. 1998;19 Suppl A: A2-11.
48. Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J. 1998;19 Suppl M:M8-14.
49. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998; 97: 1029-36.
50. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996; 3: 213-9.
51. Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. Atherosclerosis. 2000; 153: 263-72.
52. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol. 1997; 17:107-13.
53. Wirfält E, Hedblad B, Gullberg B, Mattisson I, Andrén C, Rosander U, et al. Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. Am J Epidemiol. 2001; 154: 1150-9.
54. Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007; 116: 480-8.
55. Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE, et al. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr. 2001;73: 560-6.
56. Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration among US adults. Arch Intern Med. 2001; 161: 572-6.
57. Merchant AT, Anand SS, Kelemen LE, Vuksan V, Jacobs R, Davis B, et al; SHARE and SHARE-AP Investigators. Carbohydrate intake and HDL in a multiethnic population. Am J Clin Nutr. 2007; 85:225-30.
58. Slyper A, Jurva J, Pleuss J, Hoffmann R, Gutterman D. Influence of glycemic load on HDL cholesterol in youth. Am J Clin Nutr. 2005; 81:376-9.
59. Lairon D, Play B, Jourdheuil-Rahmani D. Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. J Nutr Biochem. 2007; 18:217-27.
60. Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002; 75:11-20.
61. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003; 348:2074-81.
62. Sharman MJ, Gómez AL, Kraemer WJ, Volek JS. Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men. J Nutr. 2004;134:880-5.
63. Volek JS, Sharman MJ, Gómez AL, DiPasquale C, Roti M, Pumerantz A, et al. Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women. J Am Coll Nutr. 2004; 23:177-84.
64. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004; 292:1440-6.
65. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 2007; 85:735-41.
66. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005; 28:2823-31.
67. Watkins LL, Sherwood A, Feinglos M, Hinderliter A, Babyak M, Gullette E, et al. Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Arch Intern Med. 2003; 163: 1889-95.
68. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. Appl Physiol. 2006;100:1657-65.
69. Meckling KA, Sherfey R. A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women. Appl Physiol Nutr Metab. 2007;32:743-52.
70. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996;19:1207-13.
71. Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, et al. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr. 2006; 25:581-7.
72. Knopp RH, Fish B, Dowdy A, Retzlaff B, Walden C, Rusanu I, et al. A moderate-fat diet for combined hyperlipidemia and metabolic syndrome. Curr Atheroscler Rep. 2006; 8:492-500.
73. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004; 23: 447-56.
74. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110:227-39.
75. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-52.
76. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002; 136:493-503.
77. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ. 2002; 325:628.
78. Ebrahim S, Smith GD.Lowering blood pressure: a systematic review of sustained effects of nonpharmacological interventions. J Public Health Med. 1998;20:441-8.
79. Mulrow CD, Chiquette E, Angel L, Cornell J, Summerbell C, Anagnostelis B, et al. Dieting to reduce body weight for controlling hypertension in adults (Cochrane Review). Cochrane Database Syst Rev. 2002. CD000484.
80. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215-33.
81. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ.The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002; 15:691-6.
82. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, et al. Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA. 1996; 275:1016-22.
83. Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens. 1999 ;12(1 Pt 1):84-92.
84. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997; 277:1624-32.
85. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523-33.
86. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002; 20:1493-9.
87. Appel LJ, Miller ER 3rd, Seidler AJ, Whelton PK. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993; 153:1429-38.
88. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004; 292:2482-90.
89. He J, Whelton PK. Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence. Clin Exp Hypertens. 1999;21:785-96.
90. Ferrara LA, Raimondi AS, d'Episcopo L, Guida L, Dello Russo A, Marotta T. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000;
91. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al.; DASH Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344:3-10.
92. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G,et al; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25:1105-87.
93. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM; American Heart Association. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006; 47:296-308.
94. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-72.
95. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002; 106:2747-57.
96. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999; 159:1104-9.
97. Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation. 2007;115:1004-11.
98. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166:285-93.